Patch drug support and method for manufacturing the same

The medicinal patch support with a heavier fiber layer and bidirectional orientation addresses adhesive flow-out and delamination issues, maintaining adhesive integrity and effectiveness.

JP2024177702APending Publication Date: 2024-12-24JAPAN VILENE CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2023095982
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-06-12
Publication Date
2024-12-24

AI Technical Summary

Technical Problem

Existing medicinal patch supports experience adhesive flow-out (cold flow) and delamination issues, particularly when using highly fluid adhesives or increased adhesive amounts, leading to reduced effectiveness and potential skin and clothing contamination.

Method used

A medicinal patch support with a film layer and fiber layer laminated and integrated by adhesive fibers, featuring a heavier fiber layer basis weight of 25 g/m² and bidirectional fiber orientation on the film layer side, along with specific resin and fiber compositions to enhance adhesion and prevent delamination.

Benefits of technology

The solution effectively suppresses adhesive flow-out and reduces delamination, ensuring consistent adhesive application and improved patch effectiveness without skin or clothing contamination.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024177702000001
    Figure 2024177702000001
  • Figure 2024177702000002
    Figure 2024177702000002
Patent Text Reader

Abstract

To provide a patch drug support having a film layer and a fiber layer integrated through lamination and used for preparing a patch drug coated with an adhesive containing various drugs, and a method for manufacturing the same.SOLUTION: It is found that in a patch drug support provided with a film layer and a fiber layer including an adhesive fiber, the film layer and the fiber layer being integrated through lamination by the adhesive fiber, spaces in which an adhesive is held to be present are increased by increasing a basis weight of the fiber layer included in the patch drug support, thereby suppressing a cold flow. Specifically, it is found that the cold flow can be suppressed by setting the basis weight of the fiber layer included in the patch drug support heavier than 25 g / m2. Thus, the patch drug support capable of suppressing the cold flow can be provided.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a support for medicinal patches, in which a film layer and a fiber layer are laminated together, for use in preparing medicinal patches coated with adhesives containing various drugs, and to a method for producing the same. [Background technology]

[0002] Drug patches are used in which an adhesive (in many cases, an adhesive such as a plaster containing a drug) is applied to a drug patch support such as a fiber web, film, or a composite product thereof, for the purpose of providing various efficacies such as anti-inflammatory and analgesic pharmacological effects, cooling effects, or heating effects when applied to the human body. Such drug patches are widely known as poultices, plasters, transdermal systemic preparations, therapeutic adhesive tapes, etc.

[0003] In particular, in patches which employ a patch backing in which a film layer and a fiber layer are laminated together and an adhesive is applied to the main surface on the fiber layer side, the adhesive penetrates into the spaces between the fibers, thereby providing the effect that the adhesive is less likely to peel off from the patch backing (excellent anchoring properties), and the presence of the film layer prevents the adhesive from flowing out onto the main surface on the film layer side of the patch during use.

[0004] As a medicinal patch backing having such a configuration, a two-layer structure medicinal patch backing is known, which is provided with a film layer and a fiber layer containing adhesive fibers, and the film layer and the fiber layer are laminated together by the adhesive fibers. For example, JP 2006-326963 A (Patent Document 1) discloses a substrate for an adhesive tape in which a film and a unidirectional dry web (a dry web having a main surface with unidirectional fiber orientation) are laminated together.

[0005] In the adhesive tape substrate according to Patent Document 1, the film and the unidirectional dry web are well integrated by thermal bonding due to the adhesive fibers contained in the unidirectional dry web. In addition, Patent Document 1 also states that the basis weight of the unidirectional dry web constituting the adhesive tape substrate is 25 g / m2 in order to ensure both the peel strength with the film and the anchoring property to the adhesive. 2 It is disclosed that it is preferable that:

[0006] In addition, Patent Document 1 also includes, as a comparative example, a film and a 25 g / m 2 Cross-laid web (a dry web having a main surface with bidirectional fiber orientation, thickness: about 29 μm, density: about 862 kg / m 3 ) discloses a substrate for an adhesive tape in which the crosslay web is laminated and integrated by thermal bonding using adhesive fibers contained in the crosslay web. [Prior art documents] [Patent documents]

[0007] [Patent Document 1] JP 2006-326963 A Summary of the Invention [Problem to be solved by the invention]

[0008] The applicant of the present application has studied a medicinal patch support according to the prior art disclosed in Patent Document 1, which has a configuration comprising "a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated together by the adhesive fibers," and a medicinal patch formed by applying an adhesive to the main surface of the medicinal patch support on the fiber layer side.

[0009] As a result of the applicant's continued research, it was found that a phenomenon occurred in which the adhesive applied to the main surface on the fiber layer side flowed out from the end of the fiber layer, and thereby flowed outside the fiber layer (hereinafter sometimes referred to as cold flow).

[0010] In particular, when a highly fluid adhesive is used or when the amount of adhesive applied is increased, the amount of adhesive that flows out to the outside of the fiber layer increases significantly. As a result, there is a risk that the adhesive that flows out during use of the patch will adhere to parts of the body other than where the patch is attached, or to clothing.

[0011] Furthermore, patches are usually wrapped in packaging until use, but when the patch is removed from the packaging and used, the adhesive that has leaked out from the patch may remain in the packaging. As a result, the patch removed from the packaging does not have the specified amount of adhesive applied, and even if the patch is used, it may be difficult to provide the various expected benefits to people.

[0012] An object of the present invention is to provide a backing for a medicinal patch that is capable of suppressing cold flow, and a method for producing the same. [Means for solving the problem]

[0013] The present invention relates to “(Claim 1) A medicinal patch support comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated and integrated by the adhesive fibers, The fiber layer has a basis weight of 25 g / m 2 Heavier than A support for medicinal patches. (Claim 2) The main surface of the fiber layer on the film layer side has at least bidirectional fiber orientation in the main surface direction. 2. The support for medicinal patches according to claim 1. (Claim 3) The basis weight including the film layer and adhesive fiber is 25g / m 2 a fiber layer heavier than the film layer, and the film layer and the fiber layer are laminated together by the adhesive fiber, Step (1): preparing a film; Step (2): Weight is 25g / m 2providing a fabric including bonded fibers, the fabric having a weight greater than Step (3): Laminating the fabric and the film to prepare a laminate; Step (4): applying heat or heat and pressure to the laminate to soften or dissolve the adhesive fibers; Step (5): Cooling the laminate after the application of heat or heat and pressure; A method for producing a medicinal patch support comprising: (Claim 4) Instead of the steps (2) and (3), Step (2´): Weight is 25g / m 2 providing a fabric including adhesive fibers, the fabric having a major surface having a fiber orientation that is at least bidirectional in the major surface direction; Step (3'): Laminating the film on the main surface of the fabric to prepare a laminate; The method for producing the medicinal patch support according to claim 3, comprising: It is. Effect of the Invention

[0014] As a result of the applicant's continued research, it was found that in a "medicinal patch backing comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated and integrated by the adhesive fibers," by increasing the basis weight of the fiber layer of the medicinal patch backing, the space in which the adhesive can be retained and present is increased, and cold flow can be suppressed. Specifically, when the basis weight of the fiber layer of the medicinal patch backing is increased to 25 g / m 2 It was found that cold flow could be suppressed by making the material heavier than 100%.

[0015] Based on the above findings, the present invention can provide a backing for a medicinal patch that is capable of suppressing cold flow.

[0016] In the above-mentioned medicinal patch backing according to the present invention, the basis weight of the fiber layer is 25 g / m 2If the pressure was heavier than this, a new problem would arise in that peeling would easily occur between the film layer and the fiber layer in the medicinal patch backing (hereinafter referred to as interlayer peeling). As a result of further investigations, the applicant of the present application has found that a fiber layer having a principal surface on the film layer side has at least bidirectional fiber orientation in the principal surface direction can be used to fabricate a woven fabric having a basis weight of 25 g / m 2 It has been found that even in a medicinal patch backing having a fiber layer heavier than the above, it is possible to realize a medicinal patch backing that is less susceptible to delamination.

[0017] From the above findings, the present invention can provide a backing for a medicinal patch that can suppress cold flow and prevent delamination.

[0018] Moreover, by the method for producing a medicinal patch support according to the present invention, a medicinal patch support having the above-mentioned configuration according to the present invention can be produced and provided. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] In the present invention, various configurations, such as the following configurations, can be appropriately selected. Note that, unless otherwise specified, the various measurements described in the present invention are performed under normal pressure and at a temperature of 25°C. Furthermore, unless otherwise specified, the results of the various measurements described in the present invention are measured to a value one digit smaller than the desired value, and the desired value is calculated by rounding off the value. As a specific example, when the desired value is to the first decimal place, the value is measured to the second decimal place, and the obtained value to the first decimal place is rounded off to calculate the value to the first decimal place, and this value is the desired value. Furthermore, each upper limit value and each lower limit value exemplified in the present invention can be arbitrarily combined.

[0020] Preferred embodiments of the present invention will now be described.

[0021] The medicinal patch support of the present invention comprises a film layer and a fiber layer containing adhesive fibers, and the film layer and the fiber layer are laminated together by the adhesive fibers. Here, the film layer and the fiber layer are laminated together by the adhesive fibers means that the adhesive fibers present on the main surface of the fiber layer on the film layer side bond the fiber layer and the film layer, and both layers are laminated in a manner in which at least one of the interlayer peel strength MD and the interlayer peel strength CD described below is 0.01 N / 15 mm or more. Note that the higher the value, the stronger the laminated integration, so it is preferable that the two layers are laminated together in a manner in which at least one of the interlayer peel strength MD and the interlayer peel strength CD described below is greater than 0.36 N / 15 mm.

[0022] The type of resin constituting the film layer according to the present invention can be appropriately selected, and can be a resin listed as a constituent resin of the fiber constituting the fiber layer described later, or a resin made by mixing a plurality of such resins. In particular, if the constituent resin of the film layer contains polyethylene terephthalate (hereinafter sometimes abbreviated as PET) (more preferably, the constituent resin of the film layer is only PET), it is preferable because it can reduce the possibility that the components contained in the adhesive are affected by the film layer. In addition, it is preferable because it can prevent the problem that the components contained in the adhesive are adsorbed to the film layer and cannot be released to the human body.

[0023] Furthermore, when the constituent fibers of the fiber layer of the present invention, which will be described in detail later, are made of PET, it is preferable that the film layer is also made of PET, since this allows the realization of a patch support in which the film layer and the fiber layer are more firmly laminated together.

[0024] The film layer may also contain additives such as flame retardants, fragrances, pigments, dyes, antibacterial agents, antifungal materials, photocatalyst particles, emulsifiers, dispersants, surfactants, thickeners, etc. By containing a pigment, it is possible to provide a medicinal patch support in a color that resembles the color of skin (e.g., light orange).

[0025] The film layer according to the present invention may be a layer derived from a resin layer prepared by spreading a molten resin on the main surface of the fabric constituting the fiber layer in the medicinal patch support, or a layer derived from a film prepared in advance, such as a uniaxially stretched film or a biaxially stretched film. Of these, biaxially stretched films commercially available as "MYLAR" (Teijin DuPont Films Co., Ltd., registered trademark) and "Lumilar" (Toray Industries, Inc., registered trademark) are the most suitable, since they have excellent dimensional stability, particularly in the lamination and integration process with the fabric, and can provide a medicinal patch support that can prevent the occurrence of delamination and wrinkles in the film layer.

[0026] The basis weight and thickness of the film layer can be appropriately selected so as to realize a medicinal patch backing that prevents delamination and wrinkles in the film layer and so as to realize a medicinal patch backing having desired physical properties.

[0027] The film layer weight is 2 to 70 g / m 2 and 4 to 45 g / m 2 and 15 to 35 g / m 2 In the present invention, the "weight per unit area" is the area per square meter of the main surface. 2 The term "main surface" refers to the mass per unit area, and the main surface refers to the surface with the largest area. The thickness of the film layer may be 1.5 to 75 μm, 3 to 50 μm, or 12 to 25 μm. The "thickness" in the present invention refers to the arithmetic average value of 10 randomly selected points measured using a micrometer as specified in JIS L2318.

[0028] The basis weight and thickness of the film layer constituting the medicinal patch support can be determined by measuring the basis weight and thickness of the single film obtained by removing the fiber layer from the medicinal patch support and isolating the film layer.

[0029] The fiber layer according to the present invention is a layer of fibers containing adhesive fibers as constituent fibers, and is a layer derived from a fiber web or a fabric such as a woven fabric or knitted fabric. In particular, the fiber layer is preferably derived from a fiber web so as to realize a patch support that effectively exhibits the effect of excellent anchoring. In particular, the fiber layer is preferably derived from a fiber web containing adhesive fibers, and has at least one main surface having a bidirectional fiber orientation and the other main surface having a fiber orientation different from the fiber orientation of the one main surface, so as to realize a fiber layer having a main surface with a fiber orientation according to the present invention described later. Such a fiber layer can be a fiber layer derived from a laminated web formed by laminating a crosslay web and a unidirectional fiber web.

[0030] The cross-lay web is a fiber web formed by folding a unidirectional fiber web so that the fiber orientation is not parallel to the production direction, and in the folded parts of the unidirectional fiber web, the orientation directions of the constituent fibers of each folded unidirectional fiber web part are different from each other and not parallel to the production direction. Therefore, the main surface derived from the cross-lay web has a bidirectional fiber orientation.

[0031] The fiber layer according to the present invention includes adhesive fibers as constituent fibers. The adhesive fibers in the present invention are fibers having a resin having a softening temperature lower than that of the resin constituting the film layer (a resin that can be softened in a temperature atmosphere lower than the softening temperature of the resin constituting the film layer) or a resin having a melting point lower than the melting point of the resin constituting the film layer (a resin that can melt in a temperature atmosphere lower than the melting point of the resin constituting the film layer).

[0032] As will be described in detail in the manufacturing method of a medicinal patch support below, the adhesive fibers contained in the fabric soften or melt when exposed to heat and / or heat and pressure, and then solidify when allowed to cool, thereby bonding the fiber layer and the film to form an integrated laminate. The adhesive fibers also bond the constituent fibers of the fiber layer together.

[0033] The type of resin constituting the adhesive fiber can be appropriately selected, and known polymers such as polyolefin resins (e.g., polyethylene, polypropylene, polymethylpentene, polyolefin resins having a structure in which a part of a hydrocarbon is replaced with a nitrile group or a halogen such as fluorine or chlorine, etc.), polyester resins (e.g., polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polybutylene naphthalate, polycarbonate, polyarylate, wholly aromatic polyester resins, etc.) can be used. Note that these polymers may be either linear or branched polymers, may be block copolymers or random copolymers, and may have any three-dimensional structure or crystallinity. Furthermore, they may be a mixture of multi-component resins.

[0034] In particular, when the constituent resin of the adhesive fiber contains PET (more preferably, the constituent resin of the adhesive fiber is only PET), this is preferable because it reduces the possibility that the adhesive fiber will affect the components contained in the adhesive, and it is also preferable because it prevents the components contained in the adhesive from being adsorbed by the adhesive fiber and unable to be released to the human body. Furthermore, when the film layer according to the present invention is made of PET, this is particularly preferable because it can realize a medicinal patch support in which the film layer and the fiber layer are firmly laminated together, and it is preferable because it can realize a medicinal patch support that is highly rigid and difficult to deform, thereby preventing the occurrence of delamination and wrinkles in the film layer.

[0035] The adhesive fiber may also contain additives such as flame retardants, fragrances, pigments, dyes, antibacterial agents, antifungal materials, photocatalyst particles, emulsifiers, dispersants, surfactants, thickeners, etc. By containing a pigment, it is possible to provide a medicinal patch support in a color that resembles the color of skin (e.g., light orange).

[0036] Furthermore, when the adhesive fiber contains unstretched PET (more preferably, the constituent resin of the adhesive fiber is only unstretched PET), a medicinal patch support in which the constituent resins of the film layer and the fiber layer are all made of the same type of PET can be realized, which is preferable. This is preferable because it reduces the possibility that the components contained in the adhesive are affected, and it is also preferable because it prevents the problem that the components contained in the adhesive are adsorbed to the adhesive fiber and cannot be released to the human body. In addition, it is preferable because it is possible to realize a medicinal patch support in which the film layer and the fiber layer are more firmly laminated and integrated, and as a result, it is possible to realize a medicinal patch support that is more rigid and less likely to deform, which prevents the occurrence of delamination and wrinkles in the film layer, which is preferable.

[0037] The form of the adhesive fiber can be appropriately selected, and it can be fibril fiber, single fiber, or composite fiber such as core-sheath type, sea-island type, side-by-side type, orange type, bimetal type, etc. The adhesive fiber can be a fiber having an irregular cross section other than a fiber having a substantially circular cross section or an elliptical cross section. The irregular cross section fiber can be a fiber having a fiber cross section of a hollow shape, a polygonal shape such as a triangular shape, an alphabet character shape such as a Y-shape, an irregular shape, a multi-lobed shape, a symbol shape such as an asterisk shape, or a shape in which a plurality of these shapes are combined.

[0038] The fineness and average fiber length of the adhesive fiber are appropriately adjusted, but the fineness can be 0.5 to 30 dtex, 1 to 15 dtex, 2 to 10 dtex, or 3 to 5 dtex. The adhesive fiber can be short or long fibers cut to a specific length, or continuous fibers (fibers not cut to a specific length prepared using a direct spinning method, etc.). The average fiber length can be 15 to 120 mm, 20 to 90 mm, or 30 to 60 mm. The "fiber length" refers to the fiber length measured according to JIS L1015 (2010), 8.4.1c direct method (C method).

[0039] In addition, it is preferable that adhesive fibers are present throughout the entire fiber layer in order to provide a medicinal patch backing that is resistant to deformation due to the high rigidity of the fiber layer and prevents the occurrence of delamination.

[0040] The fiber layer may contain other fibers as constituent fibers other than the adhesive fibers. The other fibers in the present invention are fibers having a resin with a softening temperature higher than the softening temperature of the resin constituting the adhesive fibers, or a resin with a melting point higher than the melting point of the resin constituting the adhesive fibers, and mainly play a role of forming the skeleton of the fiber layer. In addition, when the fiber layer contains other fibers, it is preferable that the fiber layer is a fiber layer in which the adhesive fibers and other fibers are mixed. By mixing the adhesive fibers and other fibers, the fiber layer has a high rigidity and is difficult to deform, and it is preferable to realize a patch support that can prevent the occurrence of delamination.

[0041] The type of resin constituting the other fibers can be appropriately selected, and examples thereof include polyolefin resins (e.g., polyethylene, polypropylene, polymethylpentene, polyolefin resins having a structure in which a portion of the hydrocarbon is substituted with a nitrile group or a halogen such as fluorine or chlorine, etc.), styrene resins, polyvinyl alcohol resins, polyether resins (e.g., polyether ether ketone, polyacetal, modified polyphenylene ether, aromatic polyether ketone, etc.), polyester resins (e.g., polyethylene terephthalate, polytrimethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polybutylene naphthalate, polycarbonate, polyarylate, wholly aromatic polyester resins, etc.), polyamide resins (e.g., ethylene terephthalate, polytrimethylene terephthalate, polybutylene tere ...naphthalate, polycarbonate, polyarylate, wholly aromatic polyester resins, etc.), polyamide resins (e.g., ethylene terephthalate, polytrimethylene terephthalate, polytrimethylene terephthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polycarbonate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, polytrimethylene naphthalate, poly Known polymers such as polyimide resins, polyamideimide resins, polyamide resins (e.g., aromatic polyamide resins, aromatic polyetheramide resins, nylon resins, etc.), resins having nitrile groups (e.g., polyacrylonitrile, etc.), urethane resins, epoxy resins, polysulfone resins (e.g., polysulfone, polyethersulfone, etc.), fluorine resins (e.g., polytetrafluoroethylene, polyvinylidene fluoride, etc.), cellulose resins, polybenzimidazole resins, acrylic resins (e.g., polyacrylonitrile resins copolymerized with acrylic acid esters or methacrylic acid esters, modacrylic resins copolymerized with acrylonitrile and vinyl chloride or vinylidene chloride, etc.) can be used. These polymers may be either linear or branched polymers, may be block copolymers or random copolymers, and may have any three-dimensional structure or crystallinity. Furthermore, they may be a mixture of multiple component resins.

[0042] In particular, if the constituent resin of the other fibers contains PET (and more preferably, the constituent resin of the other fibers is only PET), this is preferable as it reduces the possibility that the components contained in the adhesive will be affected by the other fibers, and is also preferable as it prevents the problem of the components contained in the adhesive being adsorbed by the other fibers and unable to be released to the human body.

[0043] The form of the other fibers can be appropriately selected, and may be fibril fibers or single fibers, for example, composite fibers such as core-sheath type, sea-island type, side-by-side type, orange type, bimetal type, etc. The other fibers may be fibers having irregular cross sections other than fibers having a substantially circular or elliptical cross section. The irregular cross section fibers may be fibers having a fiber cross section with a hollow shape, a polygonal shape such as a triangular shape, an alphabet character shape such as a Y-shape, an irregular shape, a multi-lobed shape, a symbol shape such as an asterisk shape, or a shape in which a plurality of these shapes are combined.

[0044] The fineness and average fiber length of the other fibers are appropriately adjusted, but the fineness can be 0.5 to 30 dtex, 1 to 15 dtex, 2 to 10 dtex, or 3 to 5 dtex. The other fibers can be short fibers or long fibers cut to a specific length, or continuous fibers (such as fibers prepared using a direct spinning method that are not cut to a specific length). The average fiber length can be 15 to 120 mm, 20 to 90 mm, or 30 to 60 mm.

[0045] In addition, the other fibers can act as the skeleton of the fiber layer, but it is preferable that the other fibers are present throughout the entire fiber layer so as to provide a patch support that is less likely to deform due to the high rigidity of the fiber layer and that can prevent interlayer delamination.

[0046] As described above, when the constituent resin of the fiber constituting the fiber layer contains PET (more preferably, the constituent resin of the fiber constituting the fiber layer is only PET), it is preferable to realize a medicinal patch support in which the constituent resins of the film layer and the fiber layer are all PET. With such a medicinal patch support, it is preferable to reduce the possibility that the components contained in the adhesive are affected by the fibers constituting the fiber layer, and it is also preferable to prevent the problem that the components contained in the adhesive are adsorbed by the fibers constituting the fiber layer and cannot be released to the human body side. Furthermore, since the film layer according to the present invention is composed of PET, it is preferable to realize a medicinal patch support in which the film layer and the fiber layer are firmly laminated together. As a result, it is preferable to realize a medicinal patch support that is highly rigid and difficult to deform, and can prevent the occurrence of delamination and wrinkles in the film layer.

[0047] The ratio of the mass of adhesive fibers to the mass of other fibers in the fiber mass constituting the fiber layer is adjusted as appropriate, but can be 100:0 (the fiber layer consists only of adhesive fibers), 10:90 to 90:10, 20:80 to 80:20, 30:70 to 70:30, 40:60 to 60:40, or 50:50.

[0048] In the medicinal patch support of the present invention, the main surface of the fiber layer on the film layer side can have at least bidirectional fiber orientation in the main surface direction. Whether or not the medicinal patch support has a fiber layer that satisfies this configuration can be confirmed by the following method.

[0049] (How to check whether the material has a main surface with at least bidirectional fiber orientation) (1) The film layer is removed from the medicinal patch backing, and the fiber layer that was laminated and integrated with the film layer is collected separately. Then, it is confirmed that the adhesive fiber is present on the main surface of the collected fiber layer that was in contact with the film layer. The confirmation can be performed using a microscope photograph or an electron microscope photograph. (2) From the collected fiber layer, a test specimen (square shape with one side of 10 mm or more) is taken so that it has two opposing sides parallel to the production direction (vertical direction) of the fabric constituting the fiber layer of the medicinal patch backing, and is fixed to a mount so that the main surface that was in contact with the film layer can be exposed and observed. (3) From the fibers constituting the exposed main surface of the test piece fixed to the mount, randomly select 20 or more fibers whose length direction forms an angle of more than 5° and less than 85° clockwise with respect to the vertical direction when viewed from the main surface side. The length direction of the fibers refers to the long side direction of the smallest rectangle that encloses the fiber in a photomicrograph or electron photomicrograph of the target fiber. (4) Calculate the standard deviation from the angle that the length direction of the selected fibers makes with the longitudinal direction of the test piece and the average value of the angles. If the standard deviation is within 20, the fiber layer constituting the measurement object is determined to have fiber orientation A, which has an angle of more than 5° and less than 85° clockwise with respect to the longitudinal direction of the test piece. (5) From the fibers constituting the exposed principal surface of the test piece fixed to the mount, randomly select 20 or more fibers whose longitudinal direction forms an angle of more than 5° and less than 85° counterclockwise with respect to the longitudinal direction of the test piece when viewed from the principal surface side. (6) Calculate the standard deviation from the angle that the length direction of the selected fibers makes with the longitudinal direction of the test piece and the average value of the angles. If the standard deviation is within 20, the fiber layer constituting the measurement object is determined to have fiber orientation B, which has an angle of more than 5° and less than 85° counterclockwise with respect to the longitudinal direction of the test piece.

[0050] From the above measurement results, when the measured sample has both fiber orientation A and fiber orientation B, it is determined that the fiber layer from which the sample was taken has at least bidirectional fiber orientation. The fiber layer having at least bidirectional fiber orientation according to the present invention can be, for example, a fiber layer having a main surface derived from a crosslay web.

[0051] On the other hand, if the measured sample does not have both fiber orientations A and B, such as when the measured sample has only fiber orientation A or fiber orientation B, the fiber layer from which the sample was taken is determined to have only unidirectional fiber orientation. Such a fiber layer is, for example, a fiber layer having a main surface derived from a unidirectional fiber web.

[0052] In addition, if the fiber layer does not have any of the above-mentioned fiber orientations and the constituent fibers of the measured sample are non-uniformly oriented (the standard deviation calculated by the above-mentioned method exceeds 20), the fiber layer from which the sample was taken is determined to have no specific fiber orientation. Such a fiber layer is, for example, a fiber layer having a main surface derived from a random web.

[0053] In the medicinal patch support of the present invention, the main surface of the fiber layer facing the film layer has at least a bidirectional fiber orientation in the main surface direction, which ensures strong adhesion between the fiber layer and the film layer by the adhesive fibers, thereby preventing interlayer delamination.

[0054] The reason why such an effect is exhibited is considered to be as follows. Since the main surface of the fiber layer facing the film layer has at least a bidirectional fiber orientation, the adhesive fibers contained in the fiber layer on the main surface facing the film layer have a large number of fiber intersections that are regularly oriented and uniformly dispersed. As a result, it is believed that the adhesive fibers, which are regularly oriented and uniformly dispersed with numerous fiber intersections, uniformly adhere the fiber layer to the contact surface with the film layer, thereby forming a strong bond between the two layers.

[0055] In the present invention, the term "principal surface direction" means a direction parallel to the principal surface.

[0056] It is also preferable that the fiber layer has a plurality of layers each having a different fiber orientation from each other. By forming a patch support in which a fiber layer having such a lamination pattern and a film layer are laminated together, it is preferable because cold flow can be easily suppressed.

[0057] Furthermore, it is preferable that the principal surface of the fiber layer opposite the film layer has a fiber orientation (e.g., unidirectional fiber orientation) different from the fiber orientation (e.g., bidirectional fiber orientation) of the principal surface on the film layer side.

[0058] Whether or not a medicinal patch support has a fiber layer that satisfies the above-mentioned configuration can be confirmed by changing (2) to the following (2') in the above-mentioned (method for confirming whether or not the support has a main surface with at least bidirectional fiber orientation) and observing the fiber orientation of the main surface.

[0059] (2') From the collected fiber layer, a test specimen (square shape with one side of 10 mm or more) is collected so that it has two opposing sides parallel to the production direction (vertical direction) of the fabric constituting the fiber layer of the medicinal patch backing, and is fixed to a mount so that the main surface opposite to the main surface that was in contact with the film layer can be exposed and observed.

[0060] From the above measurement results, when the main surface opposite to the main surface in contact with the film layer in the measured sample has a fiber orientation different from the fiber orientation of the main surface on the film layer side, for example, If the measured sample has only fiber orientation A or fiber orientation B, If the measured sample has only fiber orientation between 5° counterclockwise and 5° clockwise with respect to the machine direction, When the measured sample has only fiber orientation perpendicular to the warp direction or only fiber orientation perpendicular to the weft direction The sample does not have any of the above fiber orientations, and the fibers in the sample are non-uniformly oriented (the standard deviation calculated by the above method is greater than 20) and do not have a specific fiber orientation. In this case, it is determined that the fiber orientation of the main surface of the fiber layer opposite the film layer has a different fiber orientation (e.g., unidirectional fiber orientation) from the fiber orientation of the main surface of the fiber layer facing the film layer (bidirectional fiber orientation).

[0061] The main surface of such a fiber layer opposite to the film layer may be, for example, a fiber layer having a main surface derived from a unidirectional fiber web or a random web. In particular, it is preferable that the main surface of the fiber layer opposite to the film layer has a main surface derived from a unidirectional fiber web so that the effect of preventing wrinkles from occurring in the film layer can be efficiently exhibited.

[0062] In the medicinal patch support of the present invention, the main surface of the fiber layer opposite the film layer has a fiber orientation different from the fiber orientation of the main surface on the film layer side, thereby preventing wrinkles from occurring in the film layer.

[0063] In the medicinal patch backing of the present invention, the fiber layer has a basis weight of 25 g / m 2 In order to realize a patch backing that further suppresses cold flow, the fiber layer has a basis weight of 28 g / m 2 It is preferable that the thickness is 30 g / m or more. 2 It is preferable that the thickness is 35 g / m or more. 2 It is preferable that the thickness is 40 g / m or more. 2 It is preferable that the thickness is 45 g / m or more. 2 The upper limit can be adjusted as appropriate, but in order to provide a medicinal patch backing that is less susceptible to delamination, it is preferable that the upper limit is 100 g / m 2 The following is realistic.

[0064] The thickness of the fiber layer can be appropriately selected so as to realize a patch backing that suppresses cold flow, and the thickness of the fiber layer can be 10 to 200 μm, 30 to 180 μm, or 50 to 150 μm.

[0065] The basis weight and thickness of the fiber layer constituting the medicinal patch support can be determined by measuring the basis weight and thickness of the single fiber layer obtained by removing the film layer from the medicinal patch support.

[0066] The density of the fiber layer can be appropriately selected so as to realize a patch support that suppresses cold flow, but is preferably 100 to 1000 kg / m 3 can be 150~850kg / m 3 can be 400~650kg / m 3 The density of the fiber layer is a value calculated by dividing the basis weight of the fiber layer by the thickness of the fiber layer.

[0067] The basis weight and thickness of the medicinal patch backing can be appropriately selected to realize the desired medicinal patch. The basis weight of the medicinal patch backing is 27 to 170 g / m 2 and 34 to 125 g / m 2 and 45 to 105 g / m 2 It can be.

[0068] The thickness of the medicinal patch backing can be 11.5 to 275 μm, 33 to 230 μm, or 62 to 175 μm.

[0069] The medicinal patch support of the present invention may comprise other members such as other fabrics, such as other fiber layers, other films (non-porous films or porous films), or foams (non-porous foams or porous foams) that are prepared separately. However, the medicinal patch support of the present invention is preferably a two-layer structure medicinal patch support that comprises a film layer and a fiber layer containing adhesive fibers, and the film layer and the fiber layer are laminated and integrated by the adhesive fibers.

[0070] The medicinal patch support of the present invention can suppress cold flow without having other substrates such as other fiber layers prepared separately. Therefore, it is preferable that the possibility of the components contained in the adhesive being affected, which may occur when the medicinal patch support has other substrates, can be reduced. In addition, it is preferable that the problem of the components contained in the adhesive being adsorbed by the other substrates and unable to be released to the human body can be prevented.

[0071] Then, a pressure-sensitive adhesive is applied to the main surface of the medicinal patch backing according to the present invention on the side of the fiber layer, thereby preparing a medicinal patch.

[0072] The method for producing the medicinal patch support of the present invention will be described with an example. The method for producing the medicinal patch support of the present invention (the medicinal patch support comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated and integrated by the adhesive fibers) can be appropriately selected. For example, Step (1): preparing a film; Step (2): Weight is 25g / m 2 providing a fabric including bonded fibers, the fabric having a weight greater than Step (3): Laminating the fabric and the film to prepare a laminate; Step (4): applying heat or heat and pressure to the laminate to soften or dissolve the adhesive fibers; Step (5): Cooling the laminate after the application of heat or heat and pressure; It can be manufactured through the following process.

[0073] In the step (1), the type of film to be prepared can be appropriately selected, but it is preferable to use a biaxially stretched film of polyethylene terephthalate.

[0074] In step (2), the basis weight is 25 g / m 2As the adhesive fiber-containing fabric that is heavier than the above, a laminated web formed by laminating one type of web or a plurality of types of webs can be used. Also, by using a fabric having a main surface having a fiber orientation different from that of the main surface of the fabric, it is possible to realize a medicinal patch support that is prevented from wrinkling in the film layer, which is preferable.

[0075] In step (3), the film and the fabric are superimposed such that one main surface of the fabric faces one main surface of the film to prepare a laminate.

[0076] In step (4), the temperature at which the laminate is heated is appropriately adjusted, but it is preferable to heat the laminate at a temperature equal to or higher than the softening temperature of the resin constituting the adhesive fiber and lower than the softening temperature of the resin constituting the film and the resin constituting the other fibers contained in the fabric, or to heat the laminate at a temperature equal to or higher than the melting temperature of the resin constituting the adhesive fiber and lower than the melting temperature of the resin constituting the film and the resin constituting the other fibers contained in the fabric. Note that the melting temperature of the resin mentioned above refers to the melting peak temperature that can be confirmed according to JIS K7121:2012 "Method for measuring transition temperature of plastics".

[0077] The heat treatment method can be appropriately selected, and examples of the method that can be used include heating or heating and pressurizing with a roll, heating by subjecting the material to a heater such as an oven dryer, a far-infrared heater, a dry heat dryer, or a hot air dryer, and heating the resin contained therein by irradiating the material with infrared rays without pressure.

[0078] In step (4), heat and pressure may be applied to the laminate. By applying pressure under heating conditions at a temperature equal to or higher than the softening temperature and lower than the melting temperature of the resin (e.g., unstretched polyethylene terephthalate) constituting the adhesive fiber, the unstretched fibers are crushed and the fiber shape is deformed, thereby bonding the film and the fabric and also fiber-bonding the constituent fibers of the fabric.

[0079] In step (5), the laminate is subjected to a heat treatment and then allowed to cool or is cooled, whereby the constituent fibers of the fabric are bonded to each other, thereby bonding the film layer and the fabric. A medicinal patch support can be produced in which the film layer derived from the film and the fiber layer derived from the fabric are bonded and integrated with each other by the adhesive fiber contained in the fiber layer.

[0080] Further, instead of the above-mentioned step (2) and the step (3), Step (2´): Weight is 25g / m 2 providing a fabric including adhesive fibers, the fabric having a major surface having a fiber orientation that is at least bidirectional in the major surface direction; Step (3'): Laminating the film on the main surface of the fabric to prepare a laminate; The medicinal patch support of the present invention can be manufactured by the manufacturing method of the medicinal patch support comprising the steps of:

[0081] Examples of fabrics that can be used in step (2') include a laminated web formed by laminating a crosslay web containing adhesive fibers and a unidirectional fiber web containing adhesive fibers. The laminated web may be a laminated web formed by simply overlapping the two webs, or a laminated web formed by entangling the fibers present between the layers by subjecting the webs to a needle punching process or a hydroentanglement process.

[0082] In step (3'), a fabric such as a fiber web having a main surface with at least bidirectional fiber orientation is used so that a patch support that prevents delamination can be prepared, and the fabric and the film are superimposed such that the main surface of the fabric faces the main surface of the film to prepare a laminate.

[0083] In this case, by using a fabric having another main surface having a fiber orientation different from that of the main surface, it is possible to realize a medicinal patch support that prevents wrinkles from occurring in the film layer, which is preferable.

[0084] Whether or not a fabric has one main surface having at least a bidirectional fiber orientation, and whether or not the fabric has another main surface having a fiber orientation different from the fiber orientation of the one main surface, can be confirmed by taking a test piece (square shape with one side of 10 mm or more) from the fabric and using the test piece in step (2) and step (2') described above (Method for confirming whether or not a fabric has a main surface having at least a bidirectional fiber orientation).

[0085] The medicinal patch support according to the present invention is preferably a two-layer structure medicinal patch support comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated together by the adhesive fibers, but may also be a structure in which other materials such as other fabrics, other films (non-porous films or porous films) or foams (non-porous foams or porous foams) are further laminated, such as other fiber layers prepared separately.

[0086] The method for laminating the other member can be appropriately selected, and may be a simple lamination, a laminated and integrated form bonded with a binder such as a powder binder, a spray binder, or a hot melt, or a laminated and integrated form bonded with a component such as an adhesive fiber contained in the other member. The various configurations such as the material, basis weight, and thickness of the other member can be appropriately adjusted or selected according to the embodiment required for the medicinal patch support.

[0087] Furthermore, the medicinal patch support of the present invention may be subjected to a pressure treatment step such as a reliant press treatment to smooth the surface, or may be subjected to various secondary processing steps such as a step of hot forming after punching out a shape according to the application or mode of use, a step of supporting a functional component, or a hydrophilization step to improve affinity with an adhesive.

[0088] The patch can be adjusted by applying an adhesive (in many cases, an adhesive such as a plaster containing a drug) to the main surface of the medicinal patch backing of the present invention on the side of the fiber layer. The composition and amount of the adhesive can be adjusted as appropriate, but by using the medicinal patch backing of the present invention, cold flow that occurs in the patch can be suppressed even when an adhesive with high fluidity is used or when the amount of adhesive applied is increased.

[0089] Examples of such adhesives with high fluidity include adhesives containing acrylic adhesives made of acrylic polymers; rubber-based adhesives such as styrene-isoprene-styrene block copolymers, styrene-butadiene-styrene block copolymers, polyisoprene, polyisobutylene, and polybutadiene; silicone-based adhesives such as silicone rubber, dimethylsiloxane-based, and diphenylsiloxane-based; vinyl ether-based adhesives such as polyvinyl methyl ether, polyvinyl ethyl ether, and polyvinyl isobutyl ether; vinyl ester-based adhesives such as vinyl acetate-ethylene copolymers; and polyester-based adhesives made of a carboxylic acid component such as dimethyl terephthalate, dimethyl isophthalate, and dimethyl phthalate and a polyhydric alcohol component such as ethylene glycol.

[0090] The amount of adhesive applied to the medicinal patch support is adjusted as appropriate, and the amount can be adjusted so as to provide a medicinal patch having an adhesive layer with a thickness of 20 μm or more. In particular, by using the medicinal patch support of the present invention, a medicinal patch having an adhesive layer with a thickness of 100 μm or more can be provided in which cold flow occurring in the medicinal patch is suppressed. EXAMPLES

[0091] The present invention will be specifically described below with reference to examples, but the scope of the present invention is not limited thereto.

[0092] (Fibers and films used) Unstretched PET adhesive fiber: Fineness: 4.0 dtex, fiber length: 38 mm, fiber cross-sectional shape: circular, melting point: 253°C Stretched PET fiber: Fineness: 1.1 dtex, fiber length: 38 mm, fiber cross-sectional shape: circular, melting point: 253°C Biaxially oriented PET film...Non-breathable, thickness: 12μm, basis weight: 17g / m 2 Melting point: 256℃

[0093] Comparative Example 1 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed to a flat carding machine to prepare a unidirectional fiber web. The unidirectional fiber webs were then overlapped so that the fiber orientations crossed each other to prepare a crosslay web (basis weight: 25 g / m 2 The cross-laid web thus prepared had bidirectional fiber orientation on both main surfaces. Next, one main surface of the biaxially stretched PET film was overlapped with one main surface of the crosslay web to prepare a laminate. The laminate was then fed to a calender consisting of a metal roll and an elastic roll heated to 205°C, and heat and pressure were applied to the laminate at a linear pressure of 30 kg / cm and a production speed of 11 m / min. This process softened only the unstretched PET adhesive fibers. The laminate was then cooled after being subjected to the calendar device to prepare a medicinal patch support in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fibers that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fibers.

[0094] Example 1 Crosslay web weight is 28g / m 2 Except for changing the above, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0095] Example 2 Crosslay web weight is 50g / m 2Except for changing the above, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0096] Example 3 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare a unidirectional fiber web. In addition, 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed to a flat carding machine to prepare a new unidirectional fiber web, which was then layered with the fiber orientations crossing each other to prepare a crosslay web. Then, the unidirectional fiber web and the cross-lay web were laminated to form a laminated web (basis weight: 50 g / m 2 The weight of the fiber layer derived from the unidirectional fiber web is 7 g / m 2 , of which the basis weight of the fiber layer derived from the cross-lay web is 43 g / m 2 In the laminated web thus prepared, one of the main surfaces (the main surface derived from the cross-lay web) had a bidirectional fiber orientation, and the other main surface (the main surface derived from the unidirectional fiber web) had only a unidirectional fiber orientation. Next, one of the main surfaces of the biaxially stretched PET film was laminated with the main surface of the cross-laid web of the laminated web to prepare a laminate. Except for using the laminate prepared in this manner, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0097] Example 4 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare a unidirectional fiber web. In addition, 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed to a flat carding machine to prepare a new unidirectional fiber web, which was then layered with the fiber orientations crossing each other to prepare a crosslay web. Furthermore, 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare another unidirectional fiber web. Then, the unidirectional fiber web, the crosslay web, and another unidirectional fiber web were laminated in this order to form a laminated web (basis weight: 50 g / m 2 The weight of the fiber layer derived from the unidirectional fiber web is 7 g / m 2 , the basis weight of the fiber layer derived from the cross-lay web: 30g / m 2 The basis weight of the fiber layer part derived from another unidirectional fiber web: 13 g / m 2 Both main surfaces of the laminated web thus prepared had only unidirectional fiber orientation. Next, one of the main surfaces of the biaxially stretched PET film was laminated with the main surface of another unidirectional fiber web in the laminate web to prepare a laminate. Except for using the laminated web prepared in this manner, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0098] Example 5 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare a unidirectional fiber web. In addition, 70% by mass of unstretched PET adhesive fiber and 30% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare another type of unidirectional fiber web. The unidirectional fiber webs were then stacked with different fiber orientations to prepare a crosslay web. Then, the unidirectional fiber web and the cross-lay web were laminated to form a laminated web (basis weight: 50 g / m 2The weight of the fiber layer derived from the unidirectional fiber web is 7 g / m 2 , of which the basis weight of the fiber layer derived from the cross-lay web is 43 g / m 2 In the laminated web thus prepared, one of the main surfaces (the main surface derived from the cross-lay web) had a bidirectional fiber orientation, and the other main surface (the main surface derived from the unidirectional fiber web) had only a unidirectional fiber orientation. Next, one of the main surfaces of the biaxially stretched PET film was laminated with the main surface of the cross-laid web of the laminated web to prepare a laminate. Except for using the laminate prepared in this manner, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0099] Example 6 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare a unidirectional fiber web. In addition, 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed to a flat carding machine to prepare a new unidirectional fiber web, which was then layered with the fiber orientations crossing each other to prepare a crosslay web. Next, 40% by mass of unstretched PET adhesive fiber and 60% by mass of stretched PET fiber were mixed and fed to a flat carding machine to prepare another unidirectional fiber web. Furthermore, 70% by mass of unstretched PET adhesive fiber and 30% by mass of stretched PET fiber were mixed and fed into a flat carding machine to prepare another type of unidirectional fiber web. Then, the unidirectional fiber web, the crosslay web, another unidirectional fiber web, and another type of unidirectional fiber web were laminated in this order to form a laminated web (basis weight: 50 g / m 2 The weight of the fiber layer derived from the unidirectional fiber web is 7 g / m 2 , the basis weight of the fiber layer derived from the cross-lay web: 30g / m 2The basis weight of the fiber layer part derived from another unidirectional fiber web: 6g / m 2 The basis weight of the fiber layer part derived from a different unidirectional fiber web: 7g / m 2 Both main surfaces of the laminated web thus prepared had only unidirectional fiber orientation. Next, one of the main surfaces of the biaxially stretched PET film was laminated with a main surface derived from a different type of unidirectional fiber web in the laminate web to prepare a laminate. Except for using the laminated web prepared in this manner, a medicinal patch support was prepared in the same manner as in Comparative Example 1, in which the film layer and the fiber layer were laminated together by the unstretched PET adhesive fiber that constituted the fiber layer, and the constituent fibers of the fiber layer were fiber-bonded to each other by the unstretched PET adhesive fiber.

[0100] In all of the medicinal patch backings prepared in the manner described above, the unstretched PET adhesive fibers softened and collapsed when exposed to the action of heat and pressure, and the shape of the fibers changed, thereby adhering the film to the fiber layer and also bonding the constituent fibers of the fiber layer to each other.

[0101] The physical properties of each prepared medicinal patch support were evaluated and summarized in Tables 1 and 2. For ease of understanding, the type of fiber web used to prepare the fiber layer is also listed. The fiber orientation of the main surface on the film layer side and the main surface opposite the film layer in the fiber layer of each prepared medicinal patch support are confirmed and listed. The methods for measuring various physical properties of the prepared medicinal patch support are as follows.

[0102] (Method for evaluating cold flow suppression effect) A PET film was prepared with one of its main surfaces coated with a silicone release agent. A pseudo plaster layer (thickness: 100 μm) containing a styrene / isoprene / styrene block copolymer as an adhesive and having the following composition was applied to the main surface of the PET film coated with the silicone release agent. In this way, a release film with a plaster layer was prepared. (Composition of pseudo plaster) Styrene / isoprene / styrene block copolymer: 4 parts by weight Polyisobutylene: 24 parts by weight Hydrogenated rosin ester: 30 parts by weight Liquid paraffin: 40 parts by weight The exposed fiber layer of the medicinal patch backing and the layer of the pseudo plaster body of the release film with the plaster body were then superimposed on each other and then placed in a press to apply heat and pressure (press temperature: 100°C, press pressure: 0.1 MPa) between the two main surfaces. The laminate of the medicinal patch backing and the release film with the plaster body was then allowed to cool, preparing a medicinal patch comprising a layer of the pseudo plaster body with a thickness of 150 μm. Next, a piece (square, length: 10 mm, width: 10 mm) was taken from the prepared patch so that it was parallel to the production direction (lengthwise direction) of the fabric constituting the fiber layer of the patch backing and had two opposing sides. The piece was then placed on a desk with a smooth surface, with the release film side facing the patch, and a glass plate was placed over the entire main surface of the film layer side of the patch backing. This resulted in a 3 g / cm2 pressure distribution between both main surfaces of the piece. 2 The specimen was aged for 72 hours in a 50°C atmosphere under this load. After aging, the glass plate was removed and the sections were collected. The extent to which the pseudo plaster mass had flowed outward beyond the end of the fiber layer (degree of cold flow) was visually confirmed in the collected sections. The medicinal patch backing prepared in Comparative Example 1 was rated as "X" because a large amount of the pseudo paste body flowed out beyond the end of the fiber layer. The result of Example 1, in which the amount of the pseudo paste body flowing out beyond the end of the fiber layer was less than that of the medicinal patch backing prepared in Comparative Example 1, was rated as "O". Furthermore, the result of Example 1, in which the amount of the pseudo paste body flowing out beyond the end of the fiber layer was less than that of the medicinal patch backing of Example 1, was rated as "O".

[0103] In the case of patches made using a medicinal patch backing rated as "x," when the glass plate was removed after aging, the pseudo plaster adhered to the glass plate due to the occurrence of cold flow. In such patches, the adhesive that flows out beyond the ends of the fiber layer due to cold flow is likely to adhere to parts of the body other than where the patch is attached, or to clothing. On the other hand, in the case of patches made using medicinal patch backings rated as "good" and "bad," no pseudo plaster adhered to the glass plate when the glass plate was removed after aging. In such patches, the adhesive that flows out beyond the ends of the fiber layer due to cold flow does not adhere, or does not adhere easily, to parts of the body other than where the patch is attached or to clothing.

[0104] (Method of measuring interlayer peel strength) A strip of craft tape (product name: Nitto Tape No. 712F) measuring 50 mm wide and 250 mm long was attached to each of the two main surfaces of the patch support. The tape was applied so that the production direction of the fabric constituting the fiber layer of the medicinal patch backing was parallel to the long side of the craft tape. Also, Kraft tape was attached to both main surfaces of the medicinal patch support so that the outlines of both tapes overlap when viewed from one main surface to the other. Then, a test piece (15 mm wide x 250 mm long) was cut out from the patch support. The test piece was cut out so that the production direction of the fabric constituting the fiber layer of the medicinal patch backing was parallel to the long side of the test piece. Also, The test specimen was cut so that both main surfaces were entirely covered with craft tape. In this manner, three test pieces were prepared. Then, the craft tape attached to the fiber layer side together with the fiber layer was peeled off from the test piece by 50 mm from one end to the opposite other end. After that, the laminate of the fiber layer and the craft tape peeled off from the test piece, and the remaining part of the test piece from which the laminate was peeled off (i.e., the laminate of the film layer and the craft tape) were fixed to the chucks of a constant-speed extension tensile tester (Tensilon, manufactured by Orientec Co., Ltd.) (distance between chucks: 50 mm), and the long side direction of the test piece was parallel to the tensile direction of the constant-speed extension tensile tester, and the fiber layer was pulled at a speed of 100 mm / min in an attempt to peel off the test piece. The load (unit: N / 15mm) measured until the fiber layer was completely peeled off from the film layer of the test piece was continuously recorded. At this time, the load (unit: N / 15mm) measured when the fiber layer was peeled off from the film layer of the test piece by 40mm, 80mm, 120mm, and 160mm in the long side direction of the test piece was confirmed, and the average value (unit: N / 15mm) of these four measured values ​​was calculated. This measurement was performed on three test pieces, and the average of the four measured values ​​obtained for each was taken as the interlayer peel strength MD (unit: N / 15 mm). Next, Test pieces (15 mm wide x 250 mm long) were cut out from the medicinal patch backing in the same manner as above, except that the production direction of the fabric constituting the fiber layer of the medicinal patch backing was perpendicular to the long side of the craft tape. In this manner, three test pieces were prepared. Then, the craft tape attached to the fiber layer side together with the fiber layer was peeled off from the test piece by 50 mm from one end to the opposite other end. After that, the laminate of the fiber layer and the craft tape peeled off from the test piece, and the remaining part of the test piece from which the laminate was peeled off (i.e., the laminate of the film layer and the craft tape) were fixed to the chucks of a constant-speed extension tensile tester (Tensilon, manufactured by Orientec Co., Ltd.) (distance between chucks: 50 mm), and the long side direction of the test piece was parallel to the tensile direction of the constant-speed extension tensile tester, and the fiber layer was pulled at a speed of 100 mm / min in an attempt to peel off the test piece. The load (unit: N / 15mm) measured until the fiber layer was completely peeled off from the film layer of the test piece was continuously recorded. At this time, the load (unit: N / 15mm) measured when the fiber layer was peeled off from the film layer of the test piece by 40mm, 80mm, 120mm, and 160mm in the long side direction of the test piece was confirmed, and the average value (unit: N / 15mm) of these four measured values ​​was calculated. This measurement was performed on three test pieces, and the average of the four measured values ​​obtained for each was taken as the interlayer peel strength CD (unit: N / 15 mm). In this measurement method, the higher the interlayer peel strength MD and the interlayer peel strength CD of a medicinal patch backing, the more effective it is in suppressing the occurrence of interlayer peeling.

[0105] (Method of evaluating the occurrence of wrinkles) The main surface of the prepared medicinal patch support on which the film layer was exposed was visually inspected. Those in which wrinkles were observed were rated as "△", and those in which no wrinkles were observed were rated as "◯".

[0106] [Table 1]

[0107] [Table 2]

[0108] From the results of comparing Comparative Example 1 with each Example, in "a medicinal patch backing comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated and integrated by the adhesive fibers," the basis weight of the fiber layer of the medicinal patch backing is 25 g / m 2 heavier than (more specifically, 28 g / m 2 By setting the temperature at or above this range, it was possible to suppress cold flow. In addition, the interlayer peel strength MD and the interlayer peel strength CD were significantly decreased in Examples 4 and 6. The reason for this is that when the basis weight of the fiber layer of the medicinal patch support is heavy, interlayer peeling is likely to occur. When the fiber layer of this medicinal patch support has a heavy basis weight, there is a problem in that delamination is likely to occur. However, a comparison between Examples 3 and 4, and between Examples 5 and 6 revealed the following. The medicinal patch supports of Examples 3 and 5, in which the principal surface of the fiber layer facing the film layer has at least bidirectional fiber orientation in the principal surface direction, had higher interlayer peel strengths MD and CD than the medicinal patch supports of Examples 4 and 6, in which the principal surface of the fiber layer facing the film layer has unidirectional fiber orientation in the principal surface direction. Therefore, by providing a structure in which the main surface of the fiber layer on the film layer side has at least bidirectional fiber orientation in the main surface direction, it is possible to obtain a fiber weight of 25 g / m 2 Thus, even in a medicinal patch backing having a fiber layer heavier than the above, it is possible to realize a medicinal patch backing that is less susceptible to delamination.

[0109] Furthermore, the medicinal patch support prepared in Example 3 was prevented from causing wrinkles in the film layer compared to Example 2. This result demonstrated that a medicinal patch support in which wrinkles are prevented from occurring in the film layer can be realized by providing a unidirectional fiber web on the main surface of the fiber layer opposite the film layer. [Industrial Applicability]

[0110] The medicinal patch support and the method for producing the same of the present invention can be used as a medicinal patch support for, for example, poultices, plasters, transdermal systemic preparations, or therapeutic adhesive tapes.

Claims

1. A medicinal patch support comprising a film layer and a fiber layer containing adhesive fibers, the film layer and the fiber layer being laminated and integrated by the adhesive fibers, The fiber layer has a basis weight of 25 g / m 2 Heavier than A support for medicinal patches.

2. The main surface of the fiber layer on the film layer side has at least bidirectional fiber orientation in the main surface direction. The support for medicinal patches according to claim 1.

3. The film layer and the adhesive fiber have a basis weight of 25 g / m 2 a fiber layer heavier than the film layer, and the film layer and the fiber layer are laminated together by the adhesive fiber, Step (1): preparing a film; Step (2): Weight per unit area is 25 g / m 2 providing a fabric including bonded fibers, the fabric having a weight greater than Step (3): Laminating the fabric and the film to prepare a laminate; Step (4): applying heat or heat and pressure to the laminate to soften or dissolve the adhesive fibers; Step (5): A step of cooling the laminate after the application of heat or heat and pressure; A method for producing a medicinal patch support comprising:

4. Instead of the steps (2) and (3), Step (2'): basis weight of 25 g / m 2 providing a fabric including adhesive fibers, the fabric having a major surface having a fiber orientation that is at least bidirectional in the major surface direction; Step (3'): A step of laminating the film on the main surface of the fabric to prepare a laminate; A method for producing the medicinal patch support of claim 3, comprising:

Citation Information

Patent Citations

  • Substrate for adhesive tape

    JP2006326963A